Oesophageal Candidiasis — RACP Paediatrics MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — Oral fluconazole
Oesophageal candidiasis in immunosuppressed patients requires systemic antifungal therapy with oral fluconazole (first-line). Topical agents are insufficient for oesophageal disease. IV echinocandin or amphotericin B is reserved for fluconazole-resistant or severe disease.
Reference: Therapeutic Guidelines – 2024 – Antifungal